Ian Clements - 10 Nov 2021 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
Chief Financial Officer
Signature
/s/ Jody Howe, Attorney-in-Fact
Issuer symbol
MIRM
Transactions as of
10 Nov 2021
Net transactions value
+$6,190
Form type
4
Filing time
15 Nov 2021, 15:16:01 UTC
Previous filing
01 Oct 2021
Next filing
29 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRM Common Stock Award $6,190 +458 +2.8% $13.52 17,111 10 Nov 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4 is being filed voluntarily to report the acquisition of 458 shares by the Reporting Person on November 10, 2021 pursuant to the Issuer's Employee Stock Purchase Plan.